Study to Evaluate the Efficacy and Safety of Subsequent Treatment With the Zevalin (Ibritumomab Tiuxetan) Study in Patients With Follicular Grade I-II Lymphoma After 4 Cycles of Fludarabine-Mitoxantrone-Rituximab (FMR) Therapy
Clinical trial NCT00859001 · COMPLETED
Trial details
- NCT number
- NCT00859001
- Sponsor
- University of Bologna
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.